Yosdel Soto

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Aortic Dissection

Mechanical Ventilation

Respiratory Failure

Top Venues

Journal of the American Heart Association

This page only lists publications with an associated author ORCID identifier.

Publications

Yosdel Soto, Arletty Hernández, Roger Sarduy, Victor Brito, Sylvie Marleau, Donna F Vine, Ana M Vázquez, Spencer D Proctor
Monoclonal Antibody chP3R99 Reduces Subendothelial Retention of Atherogenic Lipoproteins in Insulin-Resistant Rats: Acute Treatment Versus Long-Term Protection as an Idiotypic Vaccine for Atherosclerosis. Journal of the American Heart Association (2024)
Yosdel Soto, Arletty Hernández, Roger Sarduy, Victor Brito, Sylvie Marleau, Donna F Vine, Ana M Vázquez, Spencer D Proctor
Monoclonal Antibody chP3R99 Reduces Subendothelial Retention of Atherogenic Lipoproteins in Insulin-Resistant Rats: Acute Treatment Versus Long-Term Protection as an Idiotypic Vaccine for Atherosclerosis. Journal of the American Heart Association 13 (13) (2024)
Yosdel Soto, Arletty Hernández, Roger Sarduy, Victor Brito, Sylvie Marleau, Donna F Vine, Ana M Vázquez, Spencer D Proctor
Monoclonal Antibody chP3R99 Reduces Subendothelial Retention of Atherogenic Lipoproteins in Insulin-Resistant Rats: Acute Treatment Versus Long-Term Protection as an Idiotypic Vaccine for Atherosclerosis. Journal of the American Heart Association 13 (13) (2024)
Yosdel Soto, Arletty Hernández, Roger Sarduy, Victor Brito, Sylvie Marleau, Donna F Vine, Ana M Vázquez, Spencer D Proctor
Monoclonal Antibody chP3R99 Reduces Subendothelial Retention of Atherogenic Lipoproteins in Insulin-Resistant Rats: Acute Treatment Versus Long-Term Protection as an Idiotypic Vaccine for Atherosclerosis. Journal of the American Heart Association 13 (13) (2024)
Yosdel Soto, Arletty Hernández, Roger Sarduy, Victor Brito, Sylvie Marleau, Donna F Vine, Ana M Vázquez, Spencer D Proctor
Monoclonal Antibody chP3R99 Reduces Subendothelial Retention of Atherogenic Lipoproteins in Insulin-Resistant Rats: Acute Treatment Versus Long-Term Protection as an Idiotypic Vaccine for Atherosclerosis. Journal of the American Heart Association 13 (13) (2024)
Yosdel Soto, Arletty Hernández, Roger Sarduy, Victor Brito, Sylvie Marleau, Donna F Vine, Ana M Vázquez, Spencer D Proctor
Monoclonal Antibody chP3R99 Reduces Subendothelial Retention of Atherogenic Lipoproteins in Insulin-Resistant Rats: Acute Treatment Versus Long-Term Protection as an Idiotypic Vaccine for Atherosclerosis. Journal of the American Heart Association 13 (13) (2024)